No Data
No Data
Three points to focus on in the afternoon ~ The semiconductor stock led to a rise to the 39,700 yen level for the first time since April.
In the afternoon of the 26th, there are three points to focus on in the trading: - Nikkei average rose sharply and continued to rise for three days. Semiconductor stocks led to a rise to the 39,700 yen level since April. - The dollar-yen rate is slightly positive, aiming for 160 yen. - The top contributors to the price increase are Toshiba<8035> and Advantest<6857>. Nikkei average rose sharply and continued to rise for three days, led by semiconductor stocks, reaching the 39,700 yen level since April. The Nikkei average rose significantly for the third consecutive day, closing 553.24 yen higher than the previous day (+1.41%).
Stocks that hit the daily limit up or down in the morning session.
- Stop high <190A> Chordia Therapeutics <194A> WOLVES HAND <198A> Post Prime <3848> Data Application <4575> Canvas <5616> Rain Wind Sun <7083> AHC Group - Stop limit down * including temporary stop limit up/down (indication value)
Chordia Therapeutics, Yapri, etc.
Holder percentage of Yo Miyake's share in Chordia Therapeutics Inc. stock is 5.73%, report obligation day on June 14, 2024. Holder percentage of Mitsubishi UFJ Capital Co., Ltd. (group name) Mitsubishi UFJ Life Sciences No. 1 Investment Business Limited Liability Partnership's share in Chordia Therapeutics Inc. stock is 6.07%, report obligation day on June 14, 2024.
Insider holds 5.73% of shares in Chordia Therapeutics(190A.JP)
On Jun 21, 三宅 洋 submitted the Large Shareholding Report to Ministry of Finance to disclose its 5.73% ownership of the shares in $Chordia Therapeutics(190A.JP)$. Source: Edinet AnnouncementWhat is the
Insider holds 8.32% of shares in Chordia Therapeutics(190A.JP)
On Jun 21, ジャフコ グループ株式会社 submitted the Large Shareholding Report to Ministry of Finance to disclose its 8.32% ownership of the shares in $Chordia Therapeutics(190A.JP)$. Source: Edinet Announcement
SBI Investment holds 6.42% of shares in Chordia Therapeutics(190A.JP)
On Jun 21, SBI Investment submitted the Large Shareholding Report to Ministry of Finance to disclose its 6.42% ownership of the shares in $Chordia Therapeutics(190A.JP)$. Source: Edinet AnnouncementWh
No Data